miR‐5590‐3p‐YY1 feedback loop promotes the proliferation and migration of triple‐negative breast cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR‐5590‐3p‐YY1 feedback loop promotes the proliferation and migration of triple‐negative breast cancer cells
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-13
DOI
10.1002/jcb.29158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer
- (2019) Weimei Tang et al. Nature Communications
- MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer
- (2019) Chen Khuan Wong et al. CANCER BIOLOGY & THERAPY
- The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancer
- (2019) Manuela Malsy et al. BMC BIOCHEMISTRY
- MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer
- (2019) Flavia Biamonte et al. Scientific Reports
- miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway
- (2018) Nan Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-181d-5p-FOXP1 feedback loop modulates the progression of osteosarcoma
- (2018) Haojie Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting Transcription Factors for Cancer Treatment
- (2018) Mélanie Lambert et al. MOLECULES
- Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth
- (2018) Chunyan Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MiR-374b-5p-FOXP1 feedback loop regulates cell migration, epithelial-mesenchymal transition and chemosensitivity in ovarian cancer
- (2018) Huanling Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ZFAS1: a novel tumor-related long non-coding RNA
- (2018) Dan Dong et al. Cancer Cell International
- YY1 negatively regulates the XAF1 gene expression in prostate cancer
- (2018) B. Camacho-Moctezuma et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulatory effect of hsa-miR-5590-3P on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3 and SMAD4 transcripts
- (2018) Elham Abedini Bakhshmand et al. BIOLOGICAL CHEMISTRY
- YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein
- (2018) Xi Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2
- (2016) Feng Yan Yu et al. CANCER BIOLOGY & THERAPY
- Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells
- (2016) Zhao-Tong Wang et al. CELLULAR SIGNALLING
- YY1 plays an essential role at all stages of B-cell differentiation
- (2016) Eden Kleiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Role of microRNAs in the Pathogenesis of Herpesvirus Infection
- (2016) Diogo Piedade et al. Viruses-Basel
- MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression
- (2015) Raheleh Amirkhah et al. GENES CHROMOSOMES & CANCER
- An overview of triple negative breast cancer for surgical oncologists
- (2015) Shiva Sharma et al. SURGICAL ONCOLOGY-OXFORD
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started